UNSPSC 85662945: Revision of nonautologous tissue substitute in lower tendon, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in lower tendon, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0LWYXKZ

UNSPSC 85662945, Revision of nonautologous tissue substitute in lower tendon, external approach, is a Commodity code that shows limited recent alignment with state and local government procurement activity. The three recent opportunities tagged under this code address occupational medical surveillance, independent medical evaluations for pension disability determinations, surgical benefit program management, pharmacy benefit administration, and temporary health professional staffing—none of which involve tissue substitutes, tendon revision procedures, or orthopedic implant services. The code's nominal scope describes a surgical procedure, yet the posted solicitations encompass healthcare administration, medical record management, employee health screening, and staffing services. No recent solicitations directly procure the medical devices, biologics, or surgical services the code nominally covers. State and local buying under this code appears minimal or misclassified in available records.

The geographic spread of posted opportunities includes Arizona (City of Phoenix), California (City of Long Beach and County of Santa Clara), Washington State (Department of Transportation), Florida (Collier County), and Texas (Harris County), though these represent administrative or staffing procurement rather than tissue substitute acquisition. The Washington State Department of Transportation's RFP 20260825 for occupational medical surveillance (due October 9, 2026) and the City of Phoenix's RTMRFP26001 for independent medical evaluation services (due October 16, 2026) are the most recently posted, but neither involves the orthopedic implant or tissue-based product category the code describes. Unless your pipeline includes direct relationships with state and local orthopedic surgery programs, hospital procurement offices acquiring implants, or workers' compensation carriers managing surgical benefits, this code shows no actionable recent procurement momentum.